cryptotanshinone has been researched along with Angiogenesis, Pathologic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, K; Liu, CH; Liu, HL; Lü, J; Sun, X; Tao, YY; Zhao, ZM | 1 |
| Chen, C; Duanmu, J; Gu, J; Li, C; Liu, Z; Tao, J; Wu, Y; Xiong, B; Yang, A; Yin, X; Zhang, L | 1 |
| Lin, J; Long, J; Lu, Y; Tong, L; Yuan, DP | 1 |
| Ji, Q; Wang, Y; Xu, Y; Zhang, Q | 1 |
4 other study(ies) available for cryptotanshinone and Angiogenesis, Pathologic
| Article | Year |
|---|---|
[Evaluation of cryptotanshinone inhibition of angiogenesis in human hepatic sinusoidal endothelial cells].
Topics: Animals; Animals, Genetically Modified; Cell Proliferation; Cells, Cultured; Down-Regulation; Drugs, Chinese Herbal; Endothelial Cells; Humans; Neovascularization, Pathologic; Niacinamide; Nitric Oxide; Phenanthrenes; Phenylurea Compounds; Salvia miltiorrhiza; Sorafenib; von Willebrand Factor; Zebrafish | 2016 |
Cryptotanshinone inhibits the growth and invasion of colon cancer by suppressing inflammation and tumor angiogenesis through modulating MMP/TIMP system, PI3K/Akt/mTOR signaling and HIF-1α nuclear translocation.
Topics: Active Transport, Cell Nucleus; Anti-Inflammatory Agents; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drugs, Chinese Herbal; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunomodulation; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neovascularization, Pathologic; Oncogene Protein v-akt; Phenanthrenes; Phosphatidylinositol 3-Kinases; Salvia miltiorrhiza; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1; TOR Serine-Threonine Kinases | 2018 |
The forecast of anticancer targets of cryptotanshinone based on reverse pharmacophore-based screening technology.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Databases, Factual; Drugs, Chinese Herbal; Humans; MAP Kinase Kinase 1; Neovascularization, Pathologic; Phenanthrenes; Phytotherapy; Receptors, Androgen; RNA, Messenger; Salvia miltiorrhiza | 2014 |
[Cryptotanshinone down-regulates the expression of VEGF and inhibits angiogenesis in U2OS osteosarcoma cells].
Topics: Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Down-Regulation; Drugs, Chinese Herbal; Gene Expression; Human Umbilical Vein Endothelial Cells; Humans; Microscopy, Fluorescence; Neovascularization, Pathologic; Neovascularization, Physiologic; Osteosarcoma; Phenanthrenes; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A | 2016 |